================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
TITAN PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 94-3171940
- ------------------------ --------------------------
(State of incorporation (I.R.S. employee
or organization) identification no.)
400 Oyster Point Boulevard, Suite 505,
South San Francisco, California 94080
- --------------------------------------------------------------------------------
(Address of principal executive offices) (zip code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A(c), please check the following box [x]
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A(d), please check the following box [_]
Securities Act registration statement file number to which this form relates:
______________________
(If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each class is to be Registered
- ------------------- ------------------------------
Common Stock, $.001 par value American Stock Exchange
Redeemable Class A Warrants American Stock Exchange
Securities to be registered pursuant to Section 12(g) of the Act: None
2
<PAGE>
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1. DESCRIPTION OF REGISTRANTS'S SECURITIES TO BE REGISTERED.
The Information called for by this Item 1 is incorporated herein by
reference from the Registrant's Registration Statement on Form S-1
(File No. 33-99386) filed with the Securities and Exchange
Commission.
ITEM 2. EXHIBITS
None.
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Date: November 11, 1998 TITAN PHARMACEUTICALS, INC.
By: /s/ ROBERT E. FARRELL
-----------------------------------------
Robert E. Farrell
Executive Vice President and Chief
Financial Officer
3
